The European Medicines Agency’s Committee for Medicinal Products for Human Use previously issued a positive opinion ...

NEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...

Fintel reports that on December 12, 2025, Jefferies initiated coverage of Moderna (NasdaqGS:MRNA) with a Hold recommendation. Analyst Price Forecast Suggests 29.18% Upside As of December 5, 2025, the ...

The U.S. is in "big danger" of falling behind in vaccine technology research as government funding declines and vaccine ...

The U.S. Food and Drug Administration is considering adding the strongest safety warning available to COVID-19 vaccines, ...

NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...

Moderna announced Thursday that it's launched early-stage clinical trials of an HIV mRNA vaccine. The biotechnology company has teamed up with the nonprofit International AIDS Vaccine Initiative to ...

Health and Human Services Secretary Robert F. Kennedy Jr. announced Tuesday a crackdown on mRNA vaccine technology and research to develop it, following months of pressure from anti-vaccine activists.

The US Food and Drug Administration intends to put a “black box” warning on Covid-19 vaccines, according to two people familiar with the agency’s plans.

Moderna became a household name during the pandemic because of its leading-edge technology. Investors, as is often the case, extended a positive trend too far into the future. The company's story ...